Article
EGFR Exon 20 Insertion Mutations in Sinonasal Squamous Cell Carcinoma
13 Jan 2022
Abstract excerpt
Recurrent epidermal growth factor receptor (EGFR)-activating mutations have been identified in a rare form of head and neck cancer known as sinonasal squamous cell carcinoma (SNSCC), a malignant disease with a 5-year mortality rate of ~40%. Interestingly, the majority of EGFR mutations identified in patients with primary SNSCC are exon 20 insertions (Ex20ins), which is in contrast to non-small-cell lung cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
